Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins

Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

Takashi Yokota, Diane E. Milenic, Marc Whitlow et al. · PubMed · 1992 · 826 citations

Single-chain Antigen-binding Proteins, Immunology, Immunoediting +21

Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs

Aïcha Demidem, Tammy Lam, Steve Alas et al. · Cancer Biotherapy and Radiopharmaceuticals · 1997 · 397 citations

Phase I immunotoxin trial in patients with B-cell lymphoma.

E S Vitetta, Marvin J. Stone, P L Amlot et al. · PubMed · 1991 · 286 citations

Immunodeficiencies, Immunology, Immunoediting +19

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

PL Amlot, M L STONE, David Cunningham et al. · Blood · 1993 · 219 citations · Full text

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

P L Amlot, MJ Stone, David Cunningham et al. · Blood · 1993 · 188 citations · Full text